Carboplatin During Craniospinal Radiotherapy for Children With Group 3 Medulloblastoma-A New Standard of Care?-Reply.

Authors	Sarah E S Leary, Yimei Li, James M Olson
Journal	JAMA oncology (JAMA Oncol) Vol. 8 Issue 2 Pg. 302-303 (02 01 2022) ISSN: 2374-2445 [Electronic] United States
PMID	34882234 (Publication Type: Letter, Comment)
Chemical References	Carboplatin
Topics	Carboplatin (adverse effects) Cerebellar Neoplasms (drug therapy, radiotherapy) Child Combined Modality Therapy Cranial Irradiation (adverse effects) Humans Medulloblastoma (drug therapy, radiotherapy) Standard of Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!